Arca E, Tastan H, Erbil A, Sezer E, Koç E, Kurumlu Z
J Dermatol 2006;33(5):338-43.
A randomized and comparative study performed by Arca, Tastan, Erbil, et al. looked into the safety and efficacy of narrowband UVB therapy as a solo therapy option and compared it to the combination of light therapy and topical calcipotriol. The research determined that NBUVB is safe and efficacious in the treatment of vitiligo, while adding the topical agent did not create an advantage to the therapy.